AstraZeneca’s Imfinzi gets FDA priority review for type of lung cancer – Reuters
AstraZeneca said on Thursday the U.S. Food and Drug Administration has granted its blockbuster cancer drug Imfinzi a priority review for patients …
AstraZeneca said on Thursday the U.S. Food and Drug Administration has granted its blockbuster cancer drug Imfinzi a priority review for patients …
